Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trialW. Timothy Garvey, Anuj Bhargava, Huzhang Mao et al.|The Lancet|2023Cited by 676
Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells.T Matsuoka, Yoshimitsu Yamasaki|Journal of Clinical Investigation|1997Cited by 360
The Forkhead Transcription Factor Foxo1 Bridges the JNK Pathway and the Transcription Factor PDX-1 through Its Intracellular TranslocationDan Kawamori, Yoshimitsu Yamasaki|Journal of Biological Chemistry|2005Cited by 254